Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis
| bracu.type.group | Research Publications | |
| datacite.rights | Metadata Only | |
| dc.contributor.author | Gupta A.K. | |
| dc.contributor.author | Talukder, Mesbah | |
| dc.contributor.author | Carviel J.L. | |
| dc.contributor.author | Cooper E.A. | |
| dc.contributor.author | Piguet V. | |
| dc.contributor.department | School of Pharmacy | |
| dc.date.accessioned | 2026-09-23T09:36:42Z | |
| dc.date.available | 2026-09-23T09:36:42Z | |
| dc.date.issued | 2023-09-01 | |
| dc.description.abstract | Antifungal resistance has become prevalent worldwide. Understanding the factors involved in spread of resistance allows the formulation of strategies to slow resistance development and likewise identify solutions for the treatment of highly recalcitrant fungal infections. To investigate the recent explosion of resistant strains, a literature review was performed focusing on four main areas: mechanisms of resistance to antifungal agents, diagnosis of superficial fungal infections, management, and stewardship. The use of traditional diagnostic tools such as culture, KOH analysis and minimum inhibitory concentration values on treatment were investigated and compared to the newer techniques such as molecular methods including whole genome sequencing, and polymerase chain reaction. The management of terbinafine-resistant strains is discussed. We have emphasized the need for antifungal stewardship including increasing surveillance for resistant infection. | |
| dc.description.version | Published | |
| dc.format.extent | 1706-1717 | |
| dc.identifier.citation | Gupta AK, Talukder M, Carviel JL, Cooper EA, Piguet V. Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis. J Eur Acad Dermatol Venereol. 2023; 37: 1706–1717. https://doi.org/10.1111/jdv.19217 | |
| dc.identifier.doi | 10.1111/jdv.19217 | |
| dc.identifier.issn | 09269959 | |
| dc.identifier.other | 2-s2.0-85161346573 | |
| dc.identifier.uri | https://hdl.handle.net/10361/30195 | |
| dc.language.iso | en_US | |
| dc.publisher | John Wiley and Sons Inc | |
| dc.relation.hasversion | 10.1111/jdv.19217 | |
| dc.relation.ispartof | Journal of the European Academy of Dermatology and Venereology | |
| dc.relation.ispartofseries | Journal of the European Academy of Dermatology and Venereology | |
| dc.relation.journal | Journal of the European Academy of Dermatology and Venereology | |
| dc.relation.uri | https://onlinelibrary.wiley.com/doi/10.1111/jdv.19217 | |
| dc.rights | false | |
| dc.subject | Antifungal resistance | |
| dc.subject | Superficial fungal infections | |
| dc.subject | Antifungal stewardship | |
| dc.subject | Molecular diagnostics | |
| dc.subject.lcsh | Antifungal agents. | |
| dc.subject.lcsh | Drug resistance in microorganisms. | |
| dc.title | Combatting antifungal resistance: Paradigm shift in the diagnosis and management of onychomycosis and dermatomycosis | |
| dc.type | Journal | |
| oaire.citation.issue | 9 | |
| oaire.citation.volume | 37 | |
| person.affiliation.name | Mediprobe Research Inc. | |
| person.affiliation.name | Mediprobe Research Inc. | |
| person.affiliation.name | Mediprobe Research Inc. | |
| person.affiliation.name | Mediprobe Research Inc. | |
| person.affiliation.name | University of Toronto Faculty of Medicine | |
| person.identifier.orcid | 0000-0002-8664-7723 | |
| person.identifier.scopus-author-id | 35476368700 | |
| person.identifier.scopus-author-id | 57226303680 | |
| person.identifier.scopus-author-id | 31967446400 | |
| person.identifier.scopus-author-id | 7402217090 | |
| person.identifier.scopus-author-id | 7005112367 |